# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-24-000171
Filing Date
2024-11-07
Accepted
2024-11-07 16:17:38
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | plrx-20240930.htm iXBRL | 10-Q | 1350312
2 | EX-31.1 CEO CERTIFICATION | plrx-20240930xex311.htm | EX-31.1 | 9816
3 | EX-31.2 CFO CERTIFICATION | plrx-20240930xex312.htm | EX-31.2 | 9783
4 | EX-32.1 CEO AND CFO CERTIFICATION | plrx-20240930xex321.htm | EX-32.1 | 7295
| Complete submission text file | 0001746473-24-000171.txt |  | 6713000

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | plrx-20240930.xsd | EX-101.SCH | 52460
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | plrx-20240930_cal.xml | EX-101.CAL | 59394
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | plrx-20240930_def.xml | EX-101.DEF | 242132
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | plrx-20240930_lab.xml | EX-101.LAB | 631541
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | plrx-20240930_pre.xml | EX-101.PRE | 453355
86 | EXTRACTED XBRL INSTANCE DOCUMENT | plrx-20240930_htm.xml | XML | 726441

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 241436061
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)